| Substantive Area |
Client/Project Name |
Project Type |
Scope |
| Alcohol Abuse |
Addressing the Spectrum of Alcohol Problems (ASAP) |
Randomized Control Trial |
Single center, n=340 |
| Autism |
Collaborative Programs of Excellence in Autism (CPEA) & Studies to Advance Research and Treatment (STAART) |
Longitudinal Follow up Study
Randomized Control Trial |
Multi-center, n=10,500
Two investigations:
n=150 and n=20 |
| Breast Cancer |
Clinivation, Inc. |
Longitudinal Follow up Study |
Multi-center, n=120 |
| Cardiovascular Disease and Medication Compliance |
Cardiovascular Clinical Studies, LLC (CCS) |
Randomized Control Trial |
Multi-center,
Two investigations:
n=70 and n=400 |
| Credentialing and Epidemiologic Monitoring of Nuchal Translucency |
Nuchal Translucency (NT) Education and Quality Review Program (NTQR) |
National Quality Review Program |
Over 2,200 Centers and 4,350 Providers |
| Diabetes |
Coached Care for Diabetes Project (CCDP) |
Longitudinal Follow up Study and Randomized Control Trial |
Multi-center,
n=900 and n=480 |
| Diseases of Protein Misfolding and Amyloidosis |
FoldRx and Pfizer Pharmaceuticals, Inc. |
Longitudinal Follow up Study and Open Label Trials |
Multi-center,
Four investigations:
between n=25 and n=80 per study |
| Fertility |
ReproSource |
Longitudinal Follow up Study and Clinical Evaluation |
Multi-center, n=1,100 |
| Fetal Alcohol Spectrum Disorders |
Fetal Alcohol Spectrum Disorders (FASD) |
Longitudinal Follow up Study |
Single center, n=50 |
| HIV and Hepatitis-C |
HIV Longitudinal Interrelationships of Viruses and Ethanol Study (HIV-LIVE) |
Randomized Control Trial |
Multi-center, n=400 |
| HIV and Medication Compliance |
Medication Adherence in Alcohol Abusing HIV Patients (ADHERE) |
Randomized Control Trial |
Single center, n=350 |
| Perinatal Outcomes |
Perinatal Research Branch (PRB) |
Longitudinal Follow up Study and Randomized Control Trial |
Multi-center, n=10,000 |
| Prenatal Diagnosis |
Artemis Health, Inc. / Living Microsystems |
Longitudinal Follow up Study and Diagnostic Evaluation |
Pre-Phase I: n=20;
Phase I: n=140 |
| First and Second Trimester Risk for Aneuploidy (FaSTER) |
Longitudinal Follow up Study and Clinical Evaluation |
Multi-center, n=38,000 |
| Fetal Cell Isolation Study (NIFTY I & II) |
Longitudinal Follow up Study and Diagnostic Evaluation |
Single center, n=4,000 |
| SIDS and Stillbirth |
Prenatal Alcohol in SIDS and Stillbirth Network (PASS I & II) |
Longitudinal Follow up Study |
Multi-center, n=12,000 |